GINKGO BIOWORKS HOLDINGS INC News

Express News | Ginkgo Bioworks Holdings Inc : BofA Global Research Cuts Price Objective to $1 From $1.25

Moomoo 24/7Apr 17 09:42 ET

Express News | Ginkgo Bioworks Holdings Inc: Assets Will Be Integrated Into Ginkgo AG Biologicals Services

Moomoo 24/7Apr 11 07:02 ET

Ginkgo Bioworks Holdings Inc (DNA) Reports Decline in 2023 Revenue Amid Transition and ...

Yahoo FinanceFeb 29 17:31 ET

Ginkgo Bioworks Holdings Inc (DNA) Reports Q3 2023 Financial Results

Yahoo FinanceNov 8, 2023 18:18 ET

Director Christian Henry Sells 4,499 Shares of Ginkgo Bioworks Holdings Inc (DNA)

Yahoo FinanceOct 5, 2023 01:00 ET

Express News | Ginkgo Bioworks Holdings Inc. Price Target Cut to $5.00/Share From $6.00 by Raymond James

Moomoo 24/7Mar 3, 2023 12:14 ET

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ginkgo Bioworks Holdings Inc. (DNA) Investigation

NEW YORK--(BUSINESS WIRE)--$DNA #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Soaring Eagle Acquisition Corp., whi

BusinesswireFeb 21, 2023 11:45 ET

Ginkgo Bioworks Holdings Inc. Price Target Cut to $6.00/Share From $10.50 by Raymond James

Ginkgo Bioworks Holdings Inc. Price Target Cut to $6.00/Share From $10.50 by Raymond James

Dow JonesNov 21, 2022 12:01 ET

Ginkgo Bioworks Holdings Inc Price Target Raised to $14.50/Share From $11.50 by Raymond James

Ginkgo Bioworks Holdings Inc Price Target Raised to $14.50/Share From $11.50 by Raymond James

Dow JonesAug 16, 2022 12:22 ET

Penny Stocks To Buy In May? 3 To Watch Before Next Week

If you're looking for penny stocks to buy, this market offers incredible opportunities. With how stock market volatility has been this month, a fast hand and a keen eye are crucial. When they say that

Penny StocksMay 13, 2022 09:00 ET · Markets

Ginkgo Bioworks Holdings Inc Is Maintained at Outperform by Raymond James

Ginkgo Bioworks Holdings Inc Is Maintained at Outperform by Raymond James

Dow JonesApr 25, 2022 11:25 ET

Did The Smart Money Play Ginkgo Bioworks Holdings Inc. (DNA) Correctly?

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest

YahooFinanceAUFeb 7, 2022 12:05 ET

DNA; SRNG Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ginkgo Bioworks Holdings Inc. (f/k/a Soaring Eagle Acquisition Corp.) Investors With Losses Exceeding $200K of Class Action

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or the "Company") (NYSE:DNA, SRNG))) (f/k/a Soaring Eagle Acquisition Corp.) and certa

BusinessWireJan 18, 2022 11:00 ET

Ginkgo Bioworks Holdings Inc. Is Maintained at Outperform by Raymond James

Ginkgo Bioworks Holdings Inc. Is Maintained at Outperform by Raymond James

Dow Jones NewswiresJan 14, 2022 11:20 ET

DNA; SRNG Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ginkgo Bioworks Holdings Inc. (f/k/a Soaring Eagle Acquisition Corp.) Investors of Class Action and Lead Plaintiff Deadline: January 18, 2022

NEW YORK, Nov. 23, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings

PR NewswireNov 23, 2021 10:10 ET

BRIEF-Ginkgo Bioworks Launches Cell Development Kit Service For Standardized, Low-Cost Entry To Its Cell Programming Platform

Nov 11 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N :* GINKGO BIOWORKS LAUNCHES CELL DEVELOPMENT KIT SERVICE FOR STANDARDIZED, LOW-COST ENTRY TO ITS CELL PROGRAMMING PLATFORMSource text for Eikon:

reutersNov 11, 2021 07:12 ET

BRIEF-Synlogic And Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine For The Treatment Of Homocystinuria

Nov 9 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N :* SYNLOGIC AND GINKGO BIOWORKS ANNOUNCE INVESTIGATIONAL SYNTHETIC BIOTIC MEDICINE FOR THE TREATMENT OF HOMOCYSTINURIA* SYNLOGIC- COLLABORATION GE

reutersNov 9, 2021 07:08 ET

BRIEF-Arcaea Announces $78 Mln Series A

Oct 27 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N :* ARCAEA, A COMPANY LAUNCHED ON GINKGO BIOWORKS PLATFORM, ANNOUNCES $78M SERIES A TO BUILD A NEW FOUNDATION FOR BEAUTY INDUSTRY THROUGH EXPRESSI

reutersOct 27, 2021 09:09 ET

Selecta Biosciences, Ginkgo Bioworks Join Forces To Develop Rare Disease Treatments

Selecta Biosciences Inc (NASDAQ:SELB) and Ginkgo Bioworks Holdings Inc (NYSE:DNA) have collaborated to design novel and improved therapeutic potential enzymes for orphan and rare diseases. The partner

Benzinga Real-time NewsOct 26, 2021 12:16 ET

BRIEF-Selecta Biosciences And Ginkgo Bioworks Holdings Inc Announce Partnership To Advance Treatments For Orphan And Rare Diseases

Oct 26 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N :* SELECTA BIOSCIENCES AND GINKGO BIOWORKS ANNOUNCE PARTNERSHIP TO ADVANCE TREATMENTS FOR ORPHAN AND RARE DISEASES* SELECTA BIOSCIENCES - LEVERAG

reutersOct 26, 2021 08:30 ET